MedTrace Logo

Real World Evidence of Xen45 Gel Implant in Pseudoexfoliation Glaucoma

NCT06993311 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-05-28

No results posted yet for this study

Summary

The Xen implant is an ab interno device that has been shown to be effective in reducing intraocular pressure in several types of glaucoma, although the evidence in pseudoexfoliative glaucoma is limited. The present retrospective observational study aims to increase knowledge about the long-term effectiveness and safety of the implant in pseudoexfoliative glaucoma. Researchers will compare the results with data from patients with open-angle glaucoma.

Conditions

Interventions

DEVICE

Xen Gel Stent implantation

Consecutive patients who underwent either stand-alone Xen stent insertion with MMC(mitomycin C) or combined phacoemulsification between 2018 and 2022

Sponsors & Collaborators

  • University Hospital Complex of Santiago de Compostela

    collaborator UNKNOWN

  • Xerencia de Xestión Integrada de Ferrol

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-12-01
Completion
2022-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06993311 on ClinicalTrials.gov